Ten63 Therapeutics

Durham, NC · Founded 2018 · Privately Held (backing)

Developer of novel antineoplastic therapeutics designed to create remedial medicines to targets previously believed undruggable. Ten63 Therapeutics is based in Durham, NC and was founded in 2018. It was valued at $979 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $50.5 million across 1 recorded round; the latest was a $2.1 million seed round in Jan 2021.

PMV mark · valuation
$979.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$50.5M
Last round
Seed Round
Jan 2021

Who backs Ten63 Therapeutics?

20 investors
InvestorType
SOSVVenture capital
Calm VenturesVenture capital
Draper AssociatesVenture capital
K5 GlobalVenture capital
IndieBioOther
Alexandria Venture InvestmentsOther
Gates FoundationOther
Duke Capital PartnersVenture capital
Hatteras Venture PartnersVenture capital
Draper DragonVenture capital
+ 10 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Ten63 Therapeutics investors

20 investors are on record for Ten63 Therapeutics, including SOSV, Calm Ventures, Draper Associates and K5 Global. By type, the record holds 8 venture capital firms. The seed round in Jan 2021 drew 7 investors.

Free account
More of Ten63 Therapeutics with a free account
  • ·The complete investor list: 20 names
  • ·Watch Ten63 Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 20 firms already write checks for companies like Ten63 Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View